Statistical comparison of the tumor volume changes relative to controls induced by treatment with TBG-RNAi-CK2 vs. TBG-siCK2 was not significant at the best dose of 0.01 mg/kg for each nanocapsule. This evidence concerns the gene SERPINA7 and neoplasm.